Sodium-Glucose Cotransporter 2 Inhibitors in Older Patients with CKD

J Am Soc Nephrol. 2024 Oct 1;35(10):1446-1449. doi: 10.1681/ASN.0000000000000466. Epub 2024 Jul 29.

Authors

Wisanne M Bakker¹, Ron T Gansevoort¹, Changyuan Yang¹, Glenn M Chertow², Hiddo J L Heerspink³, Priya Vart³

Affiliations

¹ Department of Nephrology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands.
² Departments of Medicine and Epidemiology and Population Health, Stanford University School of Medicine, Stanford, California.
³ Department of Clinical Pharmacy and Pharmacology, University of Groningen, University Medical Center Groningen, Groningen, The Netherlands.

PMID: 39133046
PMCID: PMC11452167 (available on 2025-10-01)
DOI: 10.1681/ASN.0000000000000466

No abstract available

MeSH terms

Aged
Diabetes Mellitus, Type 2 / complications
Diabetes Mellitus, Type 2 / drug therapy
Humans
Renal Insufficiency, Chronic* / complications
Renal Insufficiency, Chronic* / drug therapy
Sodium-Glucose Transporter 2 Inhibitors* / therapeutic use

Substances

Sodium-Glucose Transporter 2 Inhibitors